Guangdong Lifestrong Pharmacy Co., Ltd.
SZSE:301111.SZ
18.89 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 70.813 | 49.894 | 76.37 | 79.987 | 70.072 | 86.353 | 59.206 | 67.534 | 79.304 | 77.384 | 71.857 | 73.916 | 60.18 | 97.8 | 84.862 | 103.772 | 63.354 | 91.618 | 86.935 | 94.179 | 68.225 |
| Cost of Revenue
| 26.791 | -7.764 | 30.529 | 38.095 | 24.7 | 25.159 | 17.015 | 23.848 | 25.924 | 26.851 | 23.176 | 24.871 | 17.841 | 33.271 | 23.517 | 50.424 | 21.443 | 32.398 | 81.942 | 0 | 0 |
| Gross Profit
| 44.021 | 57.659 | 45.841 | 41.892 | 45.372 | 61.194 | 42.191 | 43.686 | 53.38 | 50.533 | 48.681 | 49.045 | 42.339 | 64.53 | 61.345 | 53.349 | 41.911 | 59.219 | 4.993 | 94.179 | 68.225 |
| Gross Profit Ratio
| 0.622 | 1.156 | 0.6 | 0.524 | 0.647 | 0.709 | 0.713 | 0.647 | 0.673 | 0.653 | 0.677 | 0.664 | 0.704 | 0.66 | 0.723 | 0.514 | 0.662 | 0.646 | 0.057 | 1 | 1 |
| Reseach & Development Expenses
| 1.818 | 1.99 | 2.18 | 1.683 | 2.261 | 2.221 | 2.063 | 1.992 | 2.165 | 1.946 | 2.081 | 2.421 | 2.712 | 2.733 | 2.783 | 2.522 | 2.829 | 3.21 | 0 | 0 | 0 |
| General & Administrative Expenses
| 12.667 | -6.647 | 22.844 | -3.245 | 7.864 | -8.053 | 13.653 | -0.741 | 4.682 | 5.042 | 9.461 | 0.025 | 3.52 | 8.797 | 7.842 | 4.316 | 4.828 | -13.917 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 34.674 | 9.338 | 51.586 | 35.092 | 30.164 | 42.926 | 33.979 | 28.514 | 33.03 | 36.322 | 41.59 | 32.007 | 27.915 | 36.418 | 37.005 | 45.874 | 24.739 | 33.577 | 0 | 0 | 0 |
| SG&A
| 47.34 | 2.692 | 75.386 | 42.655 | 36.348 | 34.874 | 47.632 | 27.773 | 37.712 | 43.573 | 51.051 | 32.031 | 31.435 | 45.216 | 44.847 | 49.789 | 30.417 | 19.66 | 0 | 0 | 0 |
| Other Expenses
| -1.851 | 68.006 | -28.753 | 0.933 | 1.394 | -3.759 | 0.003 | -0.101 | -0.033 | 0 | -1.218 | 0.079 | -0.07 | -6.033 | 1.517 | -29.916 | -54.215 | -1.901 | 13.131 | -67.921 | -60.093 |
| Operating Expenses
| 47.307 | 72.688 | 47.858 | 43.405 | 37.215 | 51.705 | 41.13 | 36.732 | 40.076 | 53.463 | 48.54 | 39.463 | 31.388 | 47.042 | 44.08 | -29.916 | -54.215 | 40.142 | 13.131 | -67.921 | -60.093 |
| Operating Income
| -3.286 | -15.029 | -5.821 | -1.513 | 8.156 | 6.073 | 6.02 | 11.649 | 17.44 | 0.954 | 7.027 | 14.132 | 14.615 | 18.914 | 18.777 | 23.433 | 9.139 | 20.177 | 18.124 | 26.258 | 8.132 |
| Operating Income Ratio
| -0.046 | -0.301 | -0.076 | -0.019 | 0.116 | 0.07 | 0.102 | 0.172 | 0.22 | 0.012 | 0.098 | 0.191 | 0.243 | 0.193 | 0.221 | 0.226 | 0.144 | 0.22 | 0.208 | 0.279 | 0.119 |
| Total Other Income Expenses Net
| 0.062 | 0.206 | 3.692 | 4.798 | 5.367 | 0.13 | 2.15 | -0.101 | -0.033 | -0.768 | 3.25 | 4.669 | 3.768 | -6.033 | 0.011 | 0.001 | 2.483 | 0.005 | -0.029 | -0.017 | -0.186 |
| Income Before Tax
| -3.224 | -14.823 | -2.129 | 3.289 | 13.523 | 2.314 | 6.023 | 11.548 | 17.407 | 0.186 | 5.808 | 14.212 | 14.545 | 12.881 | 18.788 | 23.434 | 11.622 | 20.182 | 18.095 | 26.241 | 7.946 |
| Income Before Tax Ratio
| -0.046 | -0.297 | -0.028 | 0.041 | 0.193 | 0.027 | 0.102 | 0.171 | 0.219 | 0.002 | 0.081 | 0.192 | 0.242 | 0.132 | 0.221 | 0.226 | 0.183 | 0.22 | 0.208 | 0.279 | 0.116 |
| Income Tax Expense
| 0.879 | -2.033 | -0.666 | -0.735 | 2.053 | 0.024 | 0.529 | 1.615 | 2.59 | 2.121 | 0.158 | 1.846 | 1.449 | 1.951 | 2.718 | 3.53 | 1.343 | 3.302 | 2.074 | 3.985 | 0.581 |
| Net Income
| -3.442 | -9.938 | -1.003 | 3.366 | 11.738 | 3.01 | 5.687 | 9.988 | 14.817 | 2.307 | 5.65 | 12.366 | 13.097 | 10.929 | 16.07 | 19.904 | 10.279 | 16.88 | 16.021 | 22.255 | 7.365 |
| Net Income Ratio
| -0.049 | -0.199 | -0.013 | 0.042 | 0.168 | 0.035 | 0.096 | 0.148 | 0.187 | 0.03 | 0.079 | 0.167 | 0.218 | 0.112 | 0.189 | 0.192 | 0.162 | 0.184 | 0.184 | 0.236 | 0.108 |
| EPS
| -0.02 | -0.064 | -0.006 | 0.021 | 0.073 | 0.02 | 0.036 | 0.062 | 0.093 | 0.015 | 0.035 | 0.077 | 0.082 | 0.068 | 0.1 | 0.16 | 0.09 | 0.11 | 0 | 0 | 0.061 |
| EPS Diluted
| -0.02 | -0.064 | -0.006 | 0.021 | 0.073 | 0.02 | 0.036 | 0.062 | 0.093 | 0.015 | 0.035 | 0.077 | 0.08 | 0.068 | 0.1 | 0.16 | 0.09 | 0.11 | 0 | 0 | 0.061 |
| EBITDA
| -2.5 | -12.461 | -2.004 | 6.451 | 16.825 | 9.149 | 9.849 | 14.568 | 20.379 | 3.78 | 8.821 | 17.653 | 17.659 | 16.751 | 22.163 | 23.453 | 11.629 | 22.446 | -108.722 | 94.179 | 68.225 |
| EBITDA Ratio
| -0.035 | -0.25 | -0.026 | 0.081 | 0.24 | 0.106 | 0.166 | 0.216 | 0.257 | 0.049 | 0.123 | 0.239 | 0.293 | 0.171 | 0.261 | 0.226 | 0.184 | 0.245 | -1.251 | 1 | 1 |